ProQR Therapeutics N.V. (PRQR) PT Raised to $34 at Citi
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $1.70 -10.53%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $34.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Alamtri Minerals Indonesia (ADMR:IJ) PT Lowered to IDR2,230 at JPMorgan
- UiPath Inc. (PATH) PT Lowered to $15 at UBS Following Investor Day
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
